
LynxCare is a Belgian scale-up company specializing in Real-World Data (RWD) infrastructure, focusing on EHR-derived insights and precision medical data. They utilize federated hospital networks and NLP-enriched datasets to provide high-quality, validated data for research. The company supports healthcare and life science organizations by closing evidence gaps with deep, precise clinical data, enabling multicenter RWE studies and publications. Their technology includes scalable European RWD infrastructure and precise small language model pipelines trained on millions of patient records. LynxCare facilitates research in areas like oncology (immuno-oncology, breast cancer, lung cancer, CLL, multiple myeloma) and cardiology (heart failure, ATTR-CM), as well as mental health. They emphasize privacy by design, secure infrastructure, and compliance with international privacy regulations, enabling scientific research within a federated data infrastructure.

LynxCare is a Belgian scale-up company specializing in Real-World Data (RWD) infrastructure, focusing on EHR-derived insights and precision medical data. They utilize federated hospital networks and NLP-enriched datasets to provide high-quality, validated data for research. The company supports healthcare and life science organizations by closing evidence gaps with deep, precise clinical data, enabling multicenter RWE studies and publications. Their technology includes scalable European RWD infrastructure and precise small language model pipelines trained on millions of patient records. LynxCare facilitates research in areas like oncology (immuno-oncology, breast cancer, lung cancer, CLL, multiple myeloma) and cardiology (heart failure, ATTR-CM), as well as mental health. They emphasize privacy by design, secure infrastructure, and compliance with international privacy regulations, enabling scientific research within a federated data infrastructure.
Headquarters: Leuven, Belgium
Product: Federated OMOP-ready clinical data platform with clinical NLP
Founded: 2015
Latest disclosed round: Series A 0,000,000 (announced 2022-06-21)
Employee count (evidence): 36
Real-world clinical data extraction, standardization and federated analytics for research and regulatory evidence generation.
2015
Healthtech / Real-World Data
0,000,000
Announced Series A to accelerate international roll-out; syndicate included Elaia, HERAN Partners, Btov Partners and PMV per disclosed summaries.
1,800,000
Seed round listed with participation from HERAN Partners and Alchemist Accelerator per disclosed summaries.
“Syndicate includes specialized healthtech and VC investors (e.g., MTIP AG, Elaia, HERAN Partners, Btov Partners, PMV, Matterwave Ventures)”